stem cells

Stem cell therapy for Parkinson’s disease, discontinuation of Pfizer’s GLP-1 drug, a pig liver clinical trial, and more biotech and pharma news from this week.

Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.

Michael Bollong and his team discovered a way to restore lung stem cells’ regenerative capacity and a potential drug for idiopathic pulmonary fibrosis.

Injecting lung stem cells into the bloodstream of mice with idiopathic pulmonary fibrosis improved their lung function, setting the stage for human trials.

Scientists recovered movement in mouse models of spinal cord injury.

After a heart attack, the damage is permanent — for now. Researchers are testing innovative ways to get the heart to regenerate muscle cells and fix itself.

Researchers use retinal organoids to screen drugs and hope to transplant them into the eyes of people with blindness in the coming years.

Genetically modified stem cells show promise in a targeted approach to taming inflammation in autoimmune diseases.

Doctors are recording a wave of wins using cord blood to heal sick children. The clinical evidence suggests that more wins may come.

Injecting muscle-derived cells into the tongue could help alleviate swallowing difficulties caused by head and neck cancer treatment.